UroGen Pharma GAAP EPS of -$0.54 misses by $0.03, revenue of $37.84M misses by $2.08M
Source: SeekingAlpha
2026-03-02 08:03:45 ET
More on UroGen Pharma
- Seeking Alpha’s Quant Rating on UroGen Pharma
- Historical earnings data for UroGen Pharma
- Financial information for UroGen Pharma
Read the full article on Seeking Alpha
For further details see:
UroGen Pharma GAAP EPS of -$0.54 misses by $0.03, revenue of $37.84M misses by $2.08M
UroGen Pharma Ltd.
NASDAQ: URGN
URGN Trading
2.17% G/L:
$19.78 Last:
146,384 Volume:
$20.18 Open:
URGN Latest News
URGN Stock Data
$1,013,880,601
41,940,767
0.31%
40
N/A
Biotechnology & Life Sciences
Healthcare
US
Princeton
